These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19734232)

  • 1. Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells.
    Li X; Shiratsuchi T; Chen G; Dellabona P; Casorati G; Franck RW; Tsuji M
    J Immunol; 2009 Oct; 183(7):4415-21. PubMed ID: 19734232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
    Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
    J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species-specific activity of glycolipid ligands for invariant NKT cells.
    Dangerfield EM; Cheng JM; Knight DA; Weinkove R; Dunbar PR; Hermans IF; Timmer MS; Stocker BL
    Chembiochem; 2012 Jun; 13(9):1349-56. PubMed ID: 22639457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cells.
    Li X; Chen G; Garcia-Navarro R; Franck RW; Tsuji M
    Immunology; 2009 Jun; 127(2):216-225. PubMed ID: 19489127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invariant NKT cells facilitate cytotoxic T-cell activation via direct recognition of CD1d on T cells.
    Qin Y; Oh S; Lim S; Shin JH; Yoon MS; Park SH
    Exp Mol Med; 2019 Oct; 51(10):1-9. PubMed ID: 31653827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells.
    Sullivan BA; Nagarajan NA; Wingender G; Wang J; Scott I; Tsuji M; Franck RW; Porcelli SA; Zajonc DM; Kronenberg M
    J Immunol; 2010 Jan; 184(1):141-53. PubMed ID: 19949076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.
    Li X; Fujio M; Imamura M; Wu D; Vasan S; Wong CH; Ho DD; Tsuji M
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13010-5. PubMed ID: 20616071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors.
    Guo T; Chamoto K; Nakatsugawa M; Ochi T; Yamashita Y; Anczurowski M; Butler MO; Hirano N
    PLoS One; 2016; 11(5):e0156114. PubMed ID: 27213277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
    Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
    Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs.
    Tatituri RV; Watts GF; Bhowruth V; Barton N; Rothchild A; Hsu FF; Almeida CF; Cox LR; Eggeling L; Cardell S; Rossjohn J; Godfrey DI; Behar SM; Besra GS; Brenner MB; Brigl M
    Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1827-32. PubMed ID: 23307809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.
    Croudace JE; Curbishley SM; Mura M; Willcox CR; Illarionov PA; Besra GS; Adams DH; Lammas DA
    BMC Immunol; 2008 Dec; 9():71. PubMed ID: 19055753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural variations at position 93 of the invariant Vα24-Jα18 α chain of human iNKT-cell TCRs strongly impact on CD1d binding.
    Sanderson JP; Waldburger-Hauri K; Garzón D; Matulis G; Mansour S; Pumphrey NJ; Lissin N; Villiger PM; Jakobsen B; Faraldo-Gómez JD; Gadola SD
    Eur J Immunol; 2012 Jan; 42(1):248-55. PubMed ID: 21956730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of C-5″ and C-6″-modified α-GalCer analogues as iNKT-cell agonists.
    Guillaume J; Pauwels N; Aspeslagh S; Zajonc DM; Elewaut D; Van Calenbergh S
    Bioorg Med Chem; 2015 Jul; 23(13):3175-82. PubMed ID: 26003341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis for recognition of CD1d/α-galactosylceramide by a human non-Vα24 T cell receptor.
    López-Sagaseta J; Kung JE; Savage PB; Gumperz J; Adams EJ
    PLoS Biol; 2012; 10(10):e1001412. PubMed ID: 23109910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-fluoro- and 3,3-difluoro-3,4-dideoxy-KRN7000 analogues as new potent immunostimulator agents: total synthesis and biological evaluation in human invariant natural killer T cells and mice.
    Hunault J; Diswall M; Frison JC; Blot V; Rocher J; Marionneau-Lambot S; Oullier T; Douillard JY; Guillarme S; Saluzzo C; Dujardin G; Jacquemin D; Graton J; Le Questel JY; Evain M; Lebreton J; Dubreuil D; Le Pendu J; Pipelier M
    J Med Chem; 2012 Feb; 55(3):1227-41. PubMed ID: 22243602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine production.
    Wojno J; Jukes JP; Ghadbane H; Shepherd D; Besra GS; Cerundolo V; Cox LR
    ACS Chem Biol; 2012 May; 7(5):847-55. PubMed ID: 22324848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.
    Clark K; Yau J; Bloom A; Wang J; Venzon DJ; Suzuki M; Pasquet L; Compton BJ; Cardell SL; Porcelli SA; Painter GF; Zajonc DM; Berzofsky JA; Terabe M
    Front Immunol; 2019; 10():2355. PubMed ID: 31649670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoreactivity to Sulfatide by Human Invariant NKT Cells.
    Stax AM; Tuengel J; Girardi E; Kitano N; Allan LL; Liu V; Zheng D; Panenka WJ; Guillaume J; Wong CH; van Calenbergh S; Zajonc DM; van den Elzen P
    J Immunol; 2017 Jul; 199(1):97-106. PubMed ID: 28526683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
    Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
    Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.